Filing Details

Accession Number:
0001209191-19-020971
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-03-22 15:32:50
Reporting Period:
2019-03-20
Accepted Time:
2019-03-22 15:32:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1142750 Amn Healthcare Services Inc AMN Services-Help Supply Services (7363) 061500476
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1158584 R Susan Salka 8840 Cypress Waters Blvd., Suite 300
Coppell TX 75019
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-03-20 58,185 $8.78 265,871 No 4 M Direct
Common Stock Disposition 2019-03-20 29,439 $47.32 236,432 No 4 D Direct
Common Stock Disposition 2019-03-20 28,746 $48.05 207,686 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 D Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2019-03-20 58,185 $0.00 58,185 $8.78
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
58,184 2020-02-02 No 4 M Direct
Footnotes
  1. A Stock-Settled Appreciation Right ("SSAR") entitles the Grantee to the right to receive shares of AMN's Common Stock ("Stock") having a value equal to the excess of the Fair Market Value of the closing price of the Stock on the trading day prior to the date of exercise over the Exercise Price multiplied by the number of SSARs exercised. The number set forth in this row represents the difference between the number of SSARs exercised (58,185), and the number of shares of Stock issued as a result of the exercise (28,746).
  2. The sale of 28,746 shares of Stock set forth in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  3. The price reported in this row represents a weighted average price of $48.048 per share. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.28, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  4. The exercise of derivative securities reported in this row was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  5. The SSARs set forth in this row were granted on February 2, 2010 pursuant to the AMN Healthcare Equity Plan and vested in three equal installments on the first, second and third anniversary of the grant date.